The Lily Device Trial

NARecruitingINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

November 30, 2025

Conditions
Chemotherapy Induced Alopecia
Interventions
DEVICE

Lily Device

Participants will wear the Lily Device at each chemotherapy session for the prescribed duration, where the device must be used during infusion and for at least two (2) hours and up to four (4) hours post infusion.

Trial Locations (5)

11590

RECRUITING

Clinical Research Alliance, Westbury

13905

RECRUITING

Guthrie - Our Lady of Lourdes Memorial Hospital, Binghamton

18840

RECRUITING

Guthrie Sayer Medical Centre, Sayre

08360

RECRUITING

Inspira Health - Mullica Hills, Mullica Hill

RECRUITING

Inspire Health - Vineland, Vineland

Sponsors
All Listed Sponsors
lead

Luminate Medical, Inc.

INDUSTRY